Researchers identify inhibitors of the SARS-CoV-2 Nsp14 N7-methyltransferase
A recent study identified inhibitors for SARS-CoV-2 non-structural protein 14 (Nsp14).
Stay updated with breaking news from Adenosine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent study identified inhibitors for SARS-CoV-2 non-structural protein 14 (Nsp14).
A new study published in the journal Science aimed to summarize the commonly studied anti-aging dietary interventions and their impact on human health and longevity.
Researchers reported on the potential association between metformin usage and coronavirus disease 2019 (COVID-19) outcomes.
- 2023 will produce significant advances for both anti-TIGIT monoclonal antibody EOS-448/GSK4428859A and adenosine A2A receptor antagonist inupadenant - Eleven clinical trials planned or ongoing... | January 9, 2023
Phase 1 data for IPH5201, a CD39-blocking monoclonal antibody, as monotherapy or in combination with durvalumab, in advanced solid tumors to be presented by partner AstraZeneca Preclinical